Market Update: THRM, JBLU, UTI, LYFT

Stocks rose on Monday morning on more positive vaccine news after AstraZeneca reported that its coronavirus vaccine candidate, developed with the University of Oxford, was 70.4% effective in preventing infection in late-stage trials. The vaccine may have even higher efficacy under a different dosing regimen and also has less stringent storage requirements than those developed by Pfizer/BioNTech and Moderna. On the economic front, IHS Markit reported stronger-than-expected readings in both its manufacturing and services indices for October. The Dow rose 0.7%, the S&P 0.4%, and the Nasdaq 0.1%. Crude oil rose nearly 1% to $43 per barrel, while gold dropped 2% to $1834 per ounce.